October 6, 2022
Ritlecitinib and Brepocitinib for Scalp Alopecia Areata Biomarkers
The treatment of AA with brepocitinib and ritlecitinib is associated with a reduction in the SALT scores. This is also related to the downregulation of TH1 cells and the upregulation of hair keratins. Future clinical trials are required to assess the safety, efficacy, dosage, and duration of treatment with JAK inhibitors. Alopecia areata (AA) is...
Development of Alopecia Areata Scale for Clinical Use
A group of 22 US board-certified dermatologists have endorsed the alopecia areata (AA) disease severity scale. The scale assesses the extent of hair loss on the scalp, hair loss in the special hair-bearing sites, previous treatment response, psychological impact, and diffuse and rapid hair loss to evaluate the severity of AA. Alopecia areata (AA) is...
Comparative Study of Different Treatment Modalities for Alopecia Areata
A combined treatment modality comprising ILC and carboxy therapy is an effective treatment option for stimulating early hair growth in individuals with AA and patchy hair loss. Alopecia areata (AA) is an autoimmune disease that has no standard medical treatment. This prevalent autoimmune condition follows an unpredictable course and is associated with patchy hair loss....